Emily Mullin is a staff writer at WIRED, covering biotechnology. Her work explores themes related to medicine and healthcare, including social issues such as the coronavirus and abortion, as well as innovative technologies like AI and CRISPR. She has been featured in outlets such as Mother Jones, Canada's National Observer, and The Austin Chronicle, among others.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Emily Mullin primarily covers scientific and healthcare topics, with a focus on medical advancements, genetic editing, psychedelic therapy, male contraception, and cancer treatment. She often cites data and government announcements in her articles.
She would likely be interested in receiving pitches from experts who can provide valuable insights into the latest developments within these fields. Researchers involved in groundbreaking studies or clinical trials related to genetic editing, novel medical treatments or therapies for serious conditions such as PTSD could capture her attention.
Given the nature of her coverage attributes and themes covered, she may also find value in receiving pitches that include access to exclusive data or information obtained through official government sources regarding regulatory changes or breakthroughs within the scientific and healthcare realms.
This information evolves through artificial intelligence and human feedback. Improve this profile .
A retinal implant allowed some people who lost their central vision to read, play cards, and recognize faces.
By: Matt Reynolds, Emily Mullin
Robert F. Kennedy, Jr. says he'll make big changes in the US government if Donald Trump is elected. He may find them hard to pull off, no matter what position he's appointed to
By: Katie Drummond, Meriem Mahdhi, Emily Mullin, Angela Watercutter, Tim Marchman, Claire Wilmot, Matt Reynolds, Leah Feiger, Vittoria Elliott, Tess Owen, James Fallows, Jake Lahut, David Gilbert, Makena Kelly
After months of campaigning, scandal, propaganda, and downright weirdness, it all comes down to this.
By: Emily Mullin, Joseph Cox, Matt Burgess, Vittoria Elliott, Will Knight, Jake Lahut, Camille Bromley, Andy Greenberg, Joel Khalili, Brenda Stolyar
You handle money for a living—you wouldn’t fall victim to a payments scam. Right? Join our WIRED Briefing on 12th December to discover the state-of-the-art techniques scammers can use to gain your trust; the ongoing impact of payment fraud on businesses; and what you can do about it.
By: Joseph Cox, Brenda Stolyar, Andy Greenberg, Vittoria Elliott, Camille Bromley, Matt Burgess, Joel Khalili, Emily Mullin, Will Knight, Jake Lahut
Ready to Face a Cyber Attack? Find Out With this AI-Powered Simulation
By: Emily Mullin
San Francisco–based Ossium Health has carried out three transplants for cancer patients using stem cells from deceased donors' bone marrow in recent months.
photo of The First Crispr Treatment Is Making Its Way to Patients image It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder. It’s finally being infused into patients.
By: Angela Watercutter, Dell Cameron, Tess Owen, Eric Geller, David Gilbert, Reece Rogers, Lola Méndez, James Fallows, Vittoria Elliott, Morgan Meaker, Zeyi Yang, Emily Mullin
The UK's Electric Freightway project is uncovering the hurdles — and opportunities — of electric HGVs
GLP-1 drugs like Ozempic are injectable medications—but a strange new market has emerged selling oral “compounded” versions online, despite a lack of evidence that they work.
By: Emily Mullin
MALVERN, PA — Are you worried about your child's mental health? A recent report by the Agency for Healthcare Research and Quality found that 20% of
(833) 317-6278 
